Search results
Is Bristol-Myers Squibb Co (BMY) Stock Modestly Undervalued?
GuruFocus.com via Yahoo Finance· 10 months agoWith a daily gain of 2% and a 3-month loss of -5.75%, Bristol-Myers Squibb Co (NYSE:BMY) has an...
Why Bristol Myers Squibb Stock Is Slumping Today
Motley Fool· 2 years agoBristol Myers Squibb (NYSE: BMY) stock was down by a noteworthy 5.4% as of 1:32 p.m. ET Monday afternoon. Bristol's share price is in retreat mode today...
Bristol-Myers Squibb Co's Dividend Analysis
GuruFocus.com via Yahoo Finance· 5 months agoBristol-Myers Squibb Co (NYSE:BMY) recently announced a dividend of $0.6 per share, payable on 2024-02-01, with the ex-dividend date set for 2024-01-04....
Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions
Benzinga via Yahoo Finance· 1 month agoThursday, Bristol Myers Squibb & Co (NYSE:BMY) posted first-quarter revenues of $11.9 billion,...
Insider Buying: CEO Christopher Boerner Acquires Shares of Bristol-Myers Squibb Co
GuruFocus.com via Yahoo Finance· 6 months agoIn a notable insider transaction, Christopher Boerner, CEO of Bristol-Myers Squibb Co (NYSE:BMY),...
Bristol Myers Squibb's Acquired Adagrasib Combo Therapy May Benefit Colorectal Cancer Patients With...
Benzinga via Yahoo Finance· 2 months agoMonday, Bristol Myers Squibb & Co (NYSE:BMY) released data from the cohorts of the Phase 1/ 2...
Beyond the Balance Sheet: What SWOT Reveals About Bristol-Myers Squibb Co (BMY)
GuruFocus.com via Yahoo Finance· 1 month agoComprehensive SWOT analysis based on the latest SEC 10-Q filing. Insight into Bristol-Myers Squibb's...
Bristol Myers Squibb's Combo Therapy Shows Sustained Benefits Over Pfizer's Cancer Drug In Kidney...
Benzinga via Yahoo Finance· 5 months agoBristol Myers Squibb & Co (NYSE:BMY) announced that Opdivo (nivolumab) plus Yervoy (ipilimumab)...
The Zacks Analyst Blog Highlights Bristol-Myers Squibb, Medtronic, Altria Group, Target and FedEx
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – April 26, 2023 – Zacks.com announces the list of stocks featured...
Bristol Myers Squibb-Exelixis Highlight Three-Year Follow Up Data From Opdivo+Cabometyx Combo...
Benzinga via Yahoo Finance· 1 year agoBristol Myers Squibb & Co (NYSE: BMY) and Exelixis Inc (NASDAQ: EXEL) announced three-year follow-up...